Cargando…

Long-Term Evaluation of Intranigral Transplantation of Human iPSC-Derived Dopamine Neurons in a Parkinson’s Disease Mouse Model

Parkinson’s disease (PD) is a neurodegenerative disorder associated with loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc). One strategy for treating PD is transplantation of DA neuroblasts. Significant advances have been made in generating midbrain DA neurons from human...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brot, Sébastien, Thamrin, Nabila Pyrenina, Bonnet, Marie-Laure, Francheteau, Maureen, Patrigeon, Maëlig, Belnoue, Laure, Gaillard, Afsaneh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140181/ https://www.ncbi.nlm.nih.gov/pubmed/35626637 http://dx.doi.org/10.3390/cells11101596

Ejemplares similares

Better Outcomes with Intranigral versus Intrastriatal Cell Transplantation: Relevance for Parkinson’s Disease
por: Droguerre, Marine, et al.
Publicado: (2022)

Characterization of Inflammation in Delayed Cortical Transplantation
por: Ballout, Nissrine, et al.
Publicado: (2019)

Analysis of the Neuroproteome Associated With Cell Therapy After Intranigral Grafting in a Mouse Model of Parkinson Disease
por: Dakik, Hassan, et al.
Publicado: (2021)

Autologous iPSC-derived dopamine neuron transplantation in a nonhuman primate Parkinson’s disease model
por: Wang, Shuyan, et al.
Publicado: (2015)

Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson’s iPSC-derived dopamine neurons
por: Zambon, Federico, et al.
Publicado: (2019)

Calcium dysregulation combined with mitochondrial failure and electrophysiological maturity converge in Parkinson’s iPSC-dopamine neurons
por: Beccano-Kelly, Dayne A., et al.
Publicado: (2023)

Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson’s disease
por: Hiller, Benjamin M., et al.
Publicado: (2022)

Organ-Chips Enhance the Maturation of Human iPSC-Derived Dopamine Neurons
por: Otero, Maria G., et al.
Publicado: (2023)

The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
por: Couch, Yvonne, et al.
Publicado: (2011)

Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo
por: Wakeman, Dustin R., et al.
Publicado: (2017)

ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons
por: Fernandes, Hugo J.R., et al.
Publicado: (2016)

Single-Cell Sequencing of iPSC-Dopamine Neurons Reconstructs Disease Progression and Identifies HDAC4 as a Regulator of Parkinson Cell Phenotypes
por: Lang, Charmaine, et al.
Publicado: (2019)

Modeling Parkinson’s Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
por: Boi, Laura, et al.
Publicado: (2020)

Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients
por: Fernández‐Santiago, Rubén, et al.
Publicado: (2015)

Using iPSC‐derived human DA neurons from opioid‐dependent subjects to study dopamine dynamics
por: Sheng, Yang, et al.
Publicado: (2016)

Pro-maturational Effects of Human iPSC-Derived Cortical Astrocytes upon iPSC-Derived Cortical Neurons
por: Hedegaard, Anne, et al.
Publicado: (2020)

Mitochondrial Phenotypes in Parkinson’s Diseases—A Focus on Human iPSC-Derived Dopaminergic Neurons
por: Heger, Leonie M., et al.
Publicado: (2021)

A pesticide and iPSC dopaminergic neuron screen identifies and classifies Parkinson-relevant pesticides
por: Paul, Kimberly C., et al.
Publicado: (2023)

Intranigral Injection of Endotoxin Suppresses Proliferation of Hippocampal Progenitor Cells
por: Darwish, Batoul, et al.
Publicado: (2019)

MAPT Genetic Variation and Neuronal Maturity Alter Isoform Expression Affecting Axonal Transport in iPSC-Derived Dopamine Neurons
por: Beevers, Joel E., et al.
Publicado: (2017)

Beneficial Effects of Hyaluronan-Based Hydrogel Implantation after Cortical Traumatic Injury
por: Lainé, Anaïs, et al.
Publicado: (2022)

Neuroprotective Effects of Neuropeptide Y against Neurodegenerative  Disease
por: Pain, Stéphanie, et al.
Publicado: (2022)

Identifying the dynamics of actin and tubulin polymerization in iPSCs and in iPSC-derived neurons
por: Magliocca, Valentina, et al.
Publicado: (2017)

Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons
por: Machado, A., et al.
Publicado: (2011)

Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation
por: Chung, Sun Young, et al.
Publicado: (2016)

Banking on iPSC- Is it Doable and is it Worthwhile
por: Solomon, Susan, et al.
Publicado: (2014)

Roadblocks in the Path of iPSC to the Clinic
por: Garreta, Elena, et al.
Publicado: (2018)

iPSC Bioprinting: Where are We at?
por: Romanazzo, Sara, et al.
Publicado: (2019)

Maturing iPSC-Derived Cardiomyocytes
por: Tang, Bor Luen
Publicado: (2020)

iPSC for modeling neurodegenerative disorders
por: Valadez-Barba, Valeria, et al.
Publicado: (2020)

iPSC-Derived Microglia as a Model to Study Inflammation in Idiopathic Parkinson’s Disease
por: Badanjak, Katja, et al.
Publicado: (2021)

Metabolomics Fingerprint Induced by the Intranigral Inoculation of Exogenous Human Alpha-Synuclein Oligomers in a Rat Model of Parkinson’s Disease
por: Murgia, Federica, et al.
Publicado: (2020)

Molecular and functional variation in iPSC-derived sensory neurons
por: Schwartzentruber, Jeremy, et al.
Publicado: (2017)

Transcriptome Dynamics of Human Neuronal Differentiation From iPSC
por: Kuruş, Meltem, et al.
Publicado: (2021)

Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson’s disease patients
por: Fernández-Santiago, Rubén, et al.
Publicado: (2019)

Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson’s disease
por: Brazdis, Razvan-Marius, et al.
Publicado: (2020)

Publisher Correction: A pesticide and iPSC dopaminergic neuron screen identifies and classifies Parkinson-relevant pesticides
por: Paul, Kimberly C., et al.
Publicado: (2023)

Parkinsonism Sac domain mutation in Synaptojanin-1 affects ciliary properties in iPSC-derived dopaminergic neurons
por: Rafiq, Nisha Mohd, et al.
Publicado: (2023)

Blockade of Intranigral and Systemic D3 Receptors Stimulates Motor Activity in the Rat Promoting a Reciprocal Interaction among Glutamate, Dopamine, and GABA
por: Rodríguez-Sánchez, Marina, et al.
Publicado: (2019)

Generation of iPSC line from a Parkinson patient with PARK7 mutation and CRISPR-edited Gibco human episomal iPSC line to mimic PARK7 mutation
por: Mazza, Melissa Conti, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nmha61t1og7m85140d7ml43n29